Key result
Higher circulating PCSK9 levels are linked to ~47% higher risk of incident type 2 diabetes.
Why the study?
PCSK9 may play a role in glucose homeostasis, but prospective data on the association between circulating PCSK9 levels and incident T2DM in large general populations remained limited.
Are higher circulating PCSK9 levels associated with an increased risk of incident type 2 diabetes in middle-aged and older adults without diabetes at baseline?
Cohort (n=38,845)
Yes
Are higher circulating PCSK9 levels associated with an increased risk of incident type 2 diabetes in middle-aged and older adults without diabetes at baseline?
Elevated circulating PCSK9 levels are independently and nonlinearly associated with a 47% higher risk of developing new-onset type 2 diabetes over 13.6 years in a large general population cohort.
Answers are grounded in this paper and cite their sources.
May inform diabetes risk stratification in observational cohorts; leaves open whether PCSK9 modulation affects glycemic outcomes.
Objectives: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of lipid metabolism, and emerging evidence suggests it may also play a role in glucose homeostasis and diabetes risk. However, prospective data on the association between circulating PCSK9 levels and incident type 2 diabetes (T2DM) in large general populations remain limited. This study aims to examine the association between circulating PCSK9 levels and the incidence of T2DM using data from the large population-based UK Biobank cohort study. Methods: We conducted a prospective population-based cohort study using data from the UK Biobank, including 38,845 individuals without diabetes at baseline (aged 40–69 years) recruited from the general population across England, Scotland, and Wales between 2006 and 2010. Plasma PCSK9 levels were measured at baseline using the Olink proximity extension assay and expressed as relative normalized protein expression units on a log2 scale. Incident T2DM was ascertained through linkage to hospital inpatient records (using the International Classification of Diseases, Ninth and Tenth Revision, codes). The association between circulating PCSK9 levels and the risk of developing incident T2DM was evaluated using Cox proportional hazards regression models. Results: The median age of participants was 58 years, with 54.8% being female. During a median follow-up period of 13.6 years, after multivariable adjustment, higher circulating PCSK9 levels were found to be significantly and nonlinearly associated with a higher risk of incident diabetes ( P for nonlinearity < 0.05). Compared with those in the lowest category of PCSK9, participants in the highest category exhibited a significantly higher incidence of T2DM (hazard ratio [HR] = 1.47; 95% confidence interval [CI], 1.12–1.93, P = 0.006). Kaplan–Meier survival analyses revealed a substantial difference in the incidence of T2DM across quartiles of PCSK9 (log-rank P < 0.0001). The relationship between circulating PCSK9 levels and new-onset T2DM remained consistent across various subgroups, including body mass index ≥30 kg/m 2 , socioeconomic factors, smoking, alcohol consumption, prediabetes, family history of diabetes, cholesterol-lowering medication use, and hormone replacement therapy. Conclusion: Higher circulating levels of PCSK9 are associated with an increased risk of new-onset T2DM. These findings underscore the potential importance of monitoring and targeting elevated PCSK9 levels to prevent T2DM in at-risk populations.
No takes yet. Share an insight, caveat, or question.
Min et al. (2026) conducted a cohort in General population without diabetes at baseline (n=38,845). Higher circulating PCSK9 levels (highest category) vs. Lowest category of circulating PCSK9 levels was evaluated on Incident type 2 diabetes mellitus (T2DM) (HR 1.47, 95% CI 1.12-1.93, p=0.006). Higher circulating PCSK9 levels (highest vs lowest category) were associated with increased risk of incident type 2 diabetes.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: